US38341P1021
US38341P1021
Gossamer Bio, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 48.471.000 | 114.701.000 | 57.7% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 211.724.000 | 174.620.000 | 21.2% | |
| Operating Income | -163.253.000 | -59.919.000 | 172.5% |
| Pretax Income | -170.458.000 | -55.635.000 | 206.4% |
| Net Income Common Stockholders | -170.370.000 | -56.528.000 | 201.4% |
| -- | -- | -- | |
| -- | -- | -- |